Sign in

CIK 0000818033

  • Accelerated filer

HERON THERAPEUTICS, INC. /DE/

Sign in to watch
Ticker
HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
942875566
Phone
+1 858-251-4400
Business address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
Former names
AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-04-21 Rosen Robert President Exercise or conversion · Employee Stock Option (Right to Buy) −19,662 925,000
2016-04-20 Rosen Robert President Exercise or conversion +4,010 $7.20 $29K 6,650
2016-04-20 Rosen Robert President Sale −4,010 $22.19 $89K 2,640
2016-04-20 Rosen Robert President Exercise or conversion · Employee Stock Option (Right to Buy) −4,010 944,662
2016-04-19 Rosen Robert President Exercise or conversion +176,328 $7.20 $1.3M 178,968
2016-04-19 Rosen Robert President Sale −60,925 $22.50 $1.4M 118,043
2016-04-19 Rosen Robert President Sale −76,949 $23.47 $1.8M 41,094
2016-04-19 Rosen Robert President Sale −32,224 $24.49 $789K 8,870
2016-04-19 Rosen Robert President Sale −6,230 $25.11 $156K 2,640
2016-04-19 Rosen Robert President Exercise or conversion · Employee Stock Option (Right to Buy) −176,328 948,672
2016-03-21 Marshall Paul SVP, Technical Operations Exercise or conversion +1,100 $9.05 $10K 2,200
2016-03-21 Marshall Paul SVP, Technical Operations Exercise or conversion · Employee Stock Option (Right to Buy) −1,100 42,800
2016-03-02 Quart Barry D Chief Executive Officer Exercise or conversion +3,472 $7.20 $25K 60,842
2016-03-02 Quart Barry D Chief Executive Officer Exercise or conversion · Employee Stock Option (Right to Buy) −3,472 934,907
2016-01-28 MANHARD KIMBERLY Executive VP, Drug Development Grant or award · Employee Stock Option (Right to Buy) +300,000 300,000
2015-12-29 Marshall Paul SVP, Technical Operations Exercise or conversion +1,100 $9.05 $10K 1,100
2015-12-29 Marshall Paul SVP, Technical Operations Exercise or conversion · Stock Option (Right to Buy) −1,100 43,900
2015-12-28 Quart Barry D Chief Executive Officer Exercise or conversion +2,315 $7.20 $17K 82,370
2015-12-28 Quart Barry D Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −2,315 938,379
2015-12-22 TANG KEVIN C Director Grant or award · Stock Option (right to buy) +17,000 17,000

Page 36 of 38 · 746 trades